|
WO1984003506A1
(en)
|
1983-03-08 |
1984-09-13 |
Commw Serum Lab Commission |
Antigenically active amino acid sequences
|
|
US4708871A
(en)
|
1983-03-08 |
1987-11-24 |
Commonwealth Serum Laboratories Commission |
Antigenically active amino acid sequences
|
|
NZ207394A
(en)
|
1983-03-08 |
1987-03-06 |
Commw Serum Lab Commission |
Detecting or determining sequence of amino acids
|
|
US4863940A
(en)
|
1984-07-26 |
1989-09-05 |
Rohm And Haas |
N-acetonyl-substituted amides and phytopathogenic fungicidal use thereof
|
|
NZ215865A
(en)
|
1985-04-22 |
1988-10-28 |
Commw Serum Lab Commission |
Method of determining the active site of a receptor-binding analogue
|
|
US4783443A
(en)
|
1986-03-03 |
1988-11-08 |
The University Of Chicago |
Amino acyl cephalosporin derivatives
|
|
US5571689A
(en)
|
1988-06-16 |
1996-11-05 |
Washington University |
Method of N-acylating peptide and proteins with diheteroatom substituted analogs of myristic acid
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
US5663143A
(en)
|
1988-09-02 |
1997-09-02 |
Dyax Corp. |
Engineered human-derived kunitz domains that inhibit human neutrophil elastase
|
|
WO1990007330A1
(en)
|
1989-01-06 |
1990-07-12 |
The Regents Of The University Of California |
Selection method for specific useful pharmaceutical compounds
|
|
EP0594600A1
(en)
|
1990-03-13 |
1994-05-04 |
FISONS plc |
Immunosuppressive macrocyclic compounds
|
|
WO1992009300A1
(en)
|
1990-11-21 |
1992-06-11 |
Iterex Pharmaceuticals Ltd. Partnership |
Synthesis of equimolar multiple oligomer mixtures, especially of oligopeptide mixtures
|
|
CA2405246A1
(en)
|
1990-12-03 |
1992-06-11 |
Genentech, Inc. |
Enrichment method for variant proteins with alterred binding properties
|
|
US5331573A
(en)
|
1990-12-14 |
1994-07-19 |
Balaji Vitukudi N |
Method of design of compounds that mimic conformational features of selected peptides
|
|
US5145684A
(en)
|
1991-01-25 |
1992-09-08 |
Sterling Drug Inc. |
Surface modified drug nanoparticles
|
|
WO1992013549A1
(en)
|
1991-02-07 |
1992-08-20 |
Research Corporation Technologies, Inc. |
Inhibition of cell proliferation by hydrophobic peptides
|
|
SE9102462D0
(sv)
|
1991-08-28 |
1991-08-28 |
Astra Ab |
New isosteric peptides
|
|
EP0541946B1
(de)
|
1991-10-07 |
1996-07-17 |
Hoechst Aktiengesellschaft |
Verfahren zur diastereoselektiven reduktiven Pinakol-Kupplung von homochiralen alpha-Aminoaldehyden
|
|
US5644048A
(en)
|
1992-01-10 |
1997-07-01 |
Isis Pharmaceuticals, Inc. |
Process for preparing phosphorothioate oligonucleotides
|
|
JPH09500087A
(ja)
|
1992-06-24 |
1997-01-07 |
コーテックス ファーマシューティカルズ インコーポレイテッド |
カルパイン活性の増大に関連した健康障害の抑制及び処置におけるカルパイン阻害剤の使用法
|
|
US5658885A
(en)
|
1993-04-27 |
1997-08-19 |
The Dupont Merck Pharmaceutical Company |
Amidino and guanidino substituted boronic acid inhibitors of trypsin-like enzymes
|
|
WO1995009859A1
(en)
|
1993-10-07 |
1995-04-13 |
The Du Pont Merck Pharmaceutical Company |
Boropeptide inhibitors of thrombin which contain a substituted pyrrolidine ring
|
|
EP0910564B1
(en)
|
1995-11-28 |
2007-10-31 |
Cephalon, Inc. |
D-amino acid derived inhibitors of cysteine and serine proteases
|
|
DE19642591A1
(de)
|
1996-10-15 |
1998-04-16 |
Basf Ag |
Neue Piperidin-Ketocarbonsäure-Derivate, deren Herstellung und Anwendung
|
|
EP0938477A4
(en)
|
1996-11-13 |
1999-12-29 |
Cephalon Inc |
BENZOTHIAZOLO AND RELATED HETEROCYCLIC GROUPS CONTAINING CYSTEIN AND SERINE PROTEASE INHIBITORS
|
|
DE19648793A1
(de)
|
1996-11-26 |
1998-05-28 |
Basf Ag |
Neue Benzamide und deren Anwendung
|
|
US5952322A
(en)
|
1996-12-05 |
1999-09-14 |
Pfizer Inc. |
Method of reducing tissue damage associated with non-cardiac ischemia using glycogen phosphorylase inhibitors
|
|
DE19650975A1
(de)
|
1996-12-09 |
1998-06-10 |
Basf Ag |
Neue heterocyclisch substituierte Benzamide und deren Anwendung
|
|
CN1245486A
(zh)
|
1996-12-11 |
2000-02-23 |
Basf公司 |
用作钙蛋白酶抑制剂的酮苯甲酰胺
|
|
EP0983243B1
(en)
|
1997-03-14 |
2004-06-16 |
Smithkline Beecham Corporation |
Novel quinoline- and naphthalenecarboxamides, pharmaceutical compositions and methods of inhibiting calpain
|
|
EP1018878B1
(en)
*
|
1997-03-14 |
2004-10-06 |
SmithKline Beecham Corporation |
Novel indolecarboxamides, pharmaceutical compositions and methodsof inhibiting calpain
|
|
US6150378A
(en)
|
1997-10-07 |
2000-11-21 |
Cephalon, Inc. |
Peptidyl-containing α-ketoamide cysteine and serine protease inhibitors
|
|
US6083944A
(en)
|
1997-10-07 |
2000-07-04 |
Cephalon, Inc. |
Quinoline-containing α-ketoamide cysteine and serine protease inhibitors
|
|
US6506559B1
(en)
|
1997-12-23 |
2003-01-14 |
Carnegie Institute Of Washington |
Genetic inhibition by double-stranded RNA
|
|
AUPP249298A0
(en)
|
1998-03-20 |
1998-04-23 |
Ag-Gene Australia Limited |
Synthetic genes and genetic constructs comprising same I
|
|
WO1999050264A1
(en)
|
1998-03-30 |
1999-10-07 |
Kyowa Hakko Kogyo Co., Ltd. |
Quinazoline derivatives
|
|
CN1306526A
(zh)
|
1998-04-20 |
2001-08-01 |
Basf公司 |
具有半胱氨酸蛋白酶抑制作用的新的杂环取代酰胺
|
|
TR200003068T2
(tr)
|
1998-04-20 |
2001-03-21 |
Basf Aktiengesellschaft |
Yeni amidler, üretimi ve kullanımı
|
|
DE19817461A1
(de)
|
1998-04-20 |
1999-10-21 |
Basf Ag |
Neue substituierte Benzamide, deren Herstellung und Anwendung
|
|
DE19818614A1
(de)
|
1998-04-20 |
1999-10-21 |
Basf Ag |
Neue substituierte Amide, deren Herstellung und Anwendung
|
|
WO1999054305A1
(de)
*
|
1998-04-20 |
1999-10-28 |
Basf Aktiengesellschaft |
Heterocyclisch substituierte amide als calpainhemmer
|
|
DE19817459A1
(de)
|
1998-04-20 |
1999-10-21 |
Basf Ag |
Neue heterozyklische substituierte Amide, Herstellung und Anwendung
|
|
EP1080074B1
(de)
|
1998-05-25 |
2006-11-08 |
Abbott GmbH & Co. KG |
Heterocyclische substituierte Amide, deren Herstellung und Verwendung
|
|
US6335155B1
(en)
|
1998-06-26 |
2002-01-01 |
Sunesis Pharmaceuticals, Inc. |
Methods for rapidly identifying small organic molecule ligands for binding to biological target molecules
|
|
US6280946B2
(en)
|
1998-08-07 |
2001-08-28 |
Boston Probes, Inc. |
PNA probes, probe sets, methods and kits pertaining to the universal detection of bacteria and eucarya
|
|
CA2355215A1
(en)
|
1998-12-28 |
2000-07-06 |
Jim Wells |
Identifying small organic molecule ligands for binding
|
|
HK1039110A1
(zh)
|
1999-03-15 |
2002-04-12 |
Axys Pharmaceuticals, Inc. |
以新颖的合成物及组分作为蛋白酶抑制剂
|
|
CN1362947A
(zh)
*
|
1999-03-15 |
2002-08-07 |
Axys药物公司 |
用作蛋白酶抑制剂的n－氰基甲基酰胺
|
|
JP2002539183A
(ja)
*
|
1999-03-16 |
2002-11-19 |
サイトビア インコーポレイテッド |
置換２−アミノベンズアミドカスパーゼインヒビターおよびその使用
|
|
SI1194425T1
(sl)
|
1999-06-23 |
2005-12-31 |
Sanofi Aventis Deutschland |
Substituirani benzimidazoli
|
|
EP1254901A4
(en)
|
2000-01-26 |
2003-03-05 |
Ono Pharmaceutical Co |
5-CHAIN CYCLIC COMPOUNDS, CONTAINING NITROGEN, AND MEDICINAL PRODUCTS CONTAINING THE SAME AS ACTIVE INGREDIENTS
|
|
EP1283728A2
(en)
|
2000-05-23 |
2003-02-19 |
Amersham Health AS |
Contrast agents
|
|
US6582827B1
(en)
|
2000-11-27 |
2003-06-24 |
The Trustees Of Columbia University In The City Of New York |
Specialized substrates for use in sequential lateral solidification processing
|
|
DE10114762A1
(de)
|
2001-03-26 |
2002-10-02 |
Knoll Gmbh |
Verwendung von Cysteinprotease-Inhibitoren
|
|
ES2386775T3
(es)
|
2001-07-23 |
2012-08-30 |
The Board Of Trustees Of The Leland Stanford Junior University |
Procedimientos y composiciones para la inhibición mediada por ARNi de la expresión génica en mamíferos
|
|
US6878743B2
(en)
|
2001-09-18 |
2005-04-12 |
Sunesis Pharmaceuticals, Inc. |
Small molecule inhibitors of caspases
|
|
US20030167490A1
(en)
|
2001-11-26 |
2003-09-04 |
Hunter Craig P. |
Gene silencing by systemic RNA interference
|
|
TW200301698A
(en)
|
2001-12-21 |
2003-07-16 |
Bristol Myers Squibb Co |
Acridone inhibitors of IMPDH enzyme
|
|
BR0307266A
(pt)
|
2002-01-31 |
2004-12-07 |
Morphochem Ag Komb Chemie |
Compostos que inibem a atividade do fator xa
|
|
JP3812678B2
(ja)
|
2002-04-25 |
2006-08-23 |
小野薬品工業株式会社 |
ジケトヒドラジン誘導体化合物およびその化合物を有効成分として含有する薬剤
|
|
JP2005535710A
(ja)
|
2002-08-09 |
2005-11-24 |
トランス テック ファーマ，インコーポレイテッド |
アリールおよびヘテロアリール化合物ならびに凝固を調節する方法
|
|
CA2851462A1
(en)
|
2003-01-08 |
2004-07-29 |
University Of Washington |
Antibacterial agents
|
|
US20040242542A1
(en)
|
2003-03-25 |
2004-12-02 |
The Regents Of The University Of California |
Compositions and methods for inducing CD81 dependent antiproliferation and for treating hepatitis C and other disorders
|
|
WO2005000793A1
(ja)
|
2003-06-26 |
2005-01-06 |
Taisho Pharmaceutical Co., Ltd. |
２位置換シクロアルキルカルボン酸誘導体
|
|
EP1493739A1
(fr)
|
2003-07-03 |
2005-01-05 |
Warner-Lambert Company LLC |
Dérivés thiophényliques d'aminoacides, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
|
|
TW200510436A
(en)
|
2003-07-21 |
2005-03-16 |
Novartis Ag |
Combinations of a cathepsin k inhibitor and a bisphosphonate in the treatment of bone metastasis, tumor growth and tumor-induced bone loss
|
|
US7501538B2
(en)
|
2003-08-08 |
2009-03-10 |
Transtech Pharma, Inc. |
Aryl and heteroaryl compounds, compositions and methods of use
|
|
EP1656359B1
(en)
|
2003-08-14 |
2012-11-28 |
Merck Sharp & Dohme Corp. |
Macrocyclic beta-secretase inhibitors for the treatment of alzheimer's disease
|
|
JPWO2005102381A1
(ja)
|
2004-04-26 |
2008-03-06 |
小野薬品工業株式会社 |
カテプシンｋ阻害薬およびｐｔｈ類を併用することを特徴とする骨密度増加剤
|
|
AU2005304962B2
(en)
|
2004-11-09 |
2009-11-19 |
Smithkline Beecham Corporation |
Glycogen phosphorylase inhibitor compounds and pharmaceutical compositions thereof
|
|
CA2619153C
(en)
*
|
2005-01-21 |
2013-12-31 |
President And Fellows Of Harvard College |
Regulation of protein synthesis by inhibition of eif4e-eif4g interaction
|
|
WO2006122237A2
(en)
|
2005-05-11 |
2006-11-16 |
University Of Florida Research Foundation, Inc. |
Imaging of neural and organ injury or damage
|
|
EP1915382A2
(en)
|
2005-08-01 |
2008-04-30 |
Phenomix Corporation |
Hepatitis c serine protease inhibitors and uses therefor
|
|
US7964624B1
(en)
|
2005-08-26 |
2011-06-21 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases
|
|
AR055395A1
(es)
|
2005-08-26 |
2007-08-22 |
Vertex Pharma |
Compuestos inhibidores de la actividad de la serina proteasa ns3-ns4a del virus de la hepatitis c
|
|
WO2007076423A2
(en)
|
2005-12-22 |
2007-07-05 |
Smithkline Beecham Corporation |
INHIBITORS OF Akt ACTIVITY
|
|
WO2007081530A2
(en)
|
2006-01-03 |
2007-07-19 |
Med Institute, Inc. |
Endoluminal medical device for local delivery of cathepsin inhibitors
|
|
US20090304631A1
(en)
|
2006-01-27 |
2009-12-10 |
David Alan Campbell |
Hepatitis c serine protease inhibitors and uses therefor
|
|
US20070207144A1
(en)
|
2006-02-16 |
2007-09-06 |
Lee Rubin |
Ubiquitin/proteasome inhibitors for the treatment of spinal muscular atrophy
|
|
WO2007109080A2
(en)
|
2006-03-16 |
2007-09-27 |
Vertex Pharmaceuticals Incorporated |
Deuterated hepatitis c protease inhibitors
|
|
EP2049490A1
(en)
|
2006-06-09 |
2009-04-22 |
Astra Zeneca AB |
N-(benzoyl)-o- [2- (pyridin- 2 -ylamino) ethyl]-l-tyrosine derivatives and related compounds as a5b1 antagonists for the treatment of solid tumors
|
|
WO2008048121A2
(en)
|
2006-10-18 |
2008-04-24 |
Lincoln University |
Macrocyclic cysteine protease inhibitors and compositions thereof
|
|
KR101578674B1
(ko)
|
2006-12-29 |
2015-12-18 |
아비에 도이치란트 게엠베하 운트 콤파니 카게 |
카복스아미드 화합물 및 칼페인 억제제로서의 이의 용도
|
|
WO2008106058A2
(en)
|
2007-02-27 |
2008-09-04 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases
|
|
JP5539864B2
(ja)
|
2007-06-12 |
2014-07-02 |
アカオゲン，インコーポレーテッド |
抗菌剤
|
|
EP2014657A1
(de)
|
2007-06-21 |
2009-01-14 |
Bayer Schering Pharma Aktiengesellschaft |
Diaminopyrimidine als Modulatoren des EP2-Rezeptors
|
|
TWI453019B
(zh)
|
2007-12-28 |
2014-09-21 |
Abbvie Deutschland |
甲醯胺化合物
|
|
TW201010700A
(en)
|
2008-08-25 |
2010-03-16 |
Piramal Lifesciences Ltd |
Diacylglycerol acyltransferase inhibitors
|
|
US8629157B2
(en)
|
2009-01-05 |
2014-01-14 |
Boehringer Ingelheim International Gmbh |
Pyrrolidine compounds which modulate the CB2 receptor
|
|
GB2467561A
(en)
|
2009-02-06 |
2010-08-11 |
Summit Corp Plc |
Dual calpain-ROS inhibitors
|
|
TWI519530B
(zh)
|
2009-02-20 |
2016-02-01 |
艾伯維德國有限及兩合公司 |
羰醯胺化合物及其作為鈣蛋白酶（ｃａｌｐａｉｎ）抑制劑之用途
|
|
US8236798B2
(en)
|
2009-05-07 |
2012-08-07 |
Abbott Gmbh & Co. Kg |
Carboxamide compounds and their use as calpain inhibitors
|
|
US8598211B2
(en)
|
2009-12-22 |
2013-12-03 |
Abbvie Inc. |
Carboxamide compounds and their use as calpain inhibitors IV
|
|
US9051304B2
(en)
|
2009-12-22 |
2015-06-09 |
AbbVie Deutschland GmbH & Co. KG |
Carboxamide compounds and their use as calpain inhibitors V
|
|
EP2519664A4
(en)
|
2009-12-30 |
2014-03-12 |
Avila Therapeutics Inc |
LIGAND-RELATED COVALENTS MODIFYING A PROTEIN
|
|
US20130079364A1
(en)
|
2010-04-21 |
2013-03-28 |
Signature Therapeutics, Inc. |
Peripheral Opioid Agonists and Peripheral Opioid Antagonists
|
|
WO2011133871A2
(en)
|
2010-04-22 |
2011-10-27 |
Alnylam Pharmaceuticals, Inc. |
5'-end derivatives
|
|
WO2011159781A2
(en)
|
2010-06-17 |
2011-12-22 |
Senomyx, Inc. |
Bitter taste modulators
|
|
US20120010235A1
(en)
|
2010-07-12 |
2012-01-12 |
Xin-Jie Chu |
N-substituted pyrrolidines
|
|
WO2012021788A2
(en)
|
2010-08-13 |
2012-02-16 |
Banyan Biomarkers |
Dipeptide calpain inhibitors
|
|
US9000025B2
(en)
|
2010-08-20 |
2015-04-07 |
Amira Pharmaceuticals, Inc. |
Autotaxin inhibitors and uses thereof
|
|
US20120095211A1
(en)
|
2010-09-22 |
2012-04-19 |
Intermune, Inc. |
Substituted proline inhibitors of hepatitis c virus replication
|
|
WO2012076639A1
(en)
|
2010-12-09 |
2012-06-14 |
Abbott Gmbh & Co. Kg |
Carboxamide compounds and their use as calpain inhibitors v
|
|
WO2012122420A2
(en)
|
2011-03-09 |
2012-09-13 |
Pharmacofore, Inc. |
Opioid prodrugs with heterocyclic linkers
|
|
AU2012225337B2
(en)
|
2011-03-09 |
2016-04-28 |
Signature Therapeutics, Inc. |
Active agent prodrugs with heterocyclic linkers
|
|
EP2697246B1
(en)
|
2011-04-15 |
2018-03-07 |
Genesis Technologies Limited |
Selective cysteine protease inhibitors and uses thereof
|
|
CN108383893A
(zh)
|
2011-08-30 |
2018-08-10 |
塔夫茨大学信托人 |
用于治疗实体瘤的fap-活化的蛋白酶体抑制剂
|
|
EP2782903B1
(en)
|
2011-11-25 |
2016-04-06 |
F.Hoffmann-La Roche Ag |
Novel pyrrolidine derivatives as inhibitors of cathepsin
|
|
JP6068505B2
(ja)
|
2012-01-11 |
2017-01-25 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
プロテアーゼ阻害剤としてのマクロ環式アミド
|
|
JP2015512427A
(ja)
*
|
2012-04-03 |
2015-04-27 |
アッヴィ・ドイチュラント・ゲー・エム・ベー・ハー・ウント・コー・カー・ゲー |
カルボキサミド化合物およびそれのカルパイン阻害薬ｖとしての使用
|
|
EP2844249A4
(en)
|
2012-05-02 |
2016-03-09 |
Univ Kansas State |
MACROCYCLIC AND PEPTIDOMIMETIC COMPOUNDS AS VIRUZIDES AGAINST 3C OR 3C LIKE PROTEASES OF PICORNIVERS, CALICIVIRES AND CORONA VIRUSES
|
|
JP2016501848A
(ja)
|
2012-11-16 |
2016-01-21 |
アデレード リサーチ アンド イノヴェーション プロプライエタリー リミテッド |
大環状化合物及びその使用
|
|
US9914740B2
(en)
|
2013-07-02 |
2018-03-13 |
Bristol-Myers Squibb Company |
Tricyclic pyrido-carboxamide derivatives as rock inhibitors
|
|
AR098414A1
(es)
*
|
2013-11-14 |
2016-05-26 |
Bristol Myers Squibb Co |
PIPERAZINAS DE PIRAZOLO SUSTITUIDO COMO INHIBIDORES DE CASEÍNA QUINASA 1 d/e
|
|
JP2017517475A
(ja)
|
2014-02-19 |
2017-06-29 |
エーテーハー チューリヒ |
化合物ライブラリーの製造方法
|
|
WO2015140199A1
(de)
*
|
2014-03-21 |
2015-09-24 |
Bayer Pharma Aktiengesellschaft |
Cyano-substituierte imidazo[1,2-a]pyridincarboxamide und ihre verwendung
|
|
BR112016027232A2
(pt)
|
2014-05-20 |
2018-06-26 |
Genentech Inc |
antibióticos macrocíclicos de amplo espectro
|
|
WO2015196086A1
(en)
|
2014-06-20 |
2015-12-23 |
The University of Montana, Missoula, MT |
NOVEL INHIBITORS OF SYSTEM Xc(-)
|
|
WO2016027284A2
(en)
|
2014-08-22 |
2016-02-25 |
Alkem Laboratories Ltd. |
Piperidine ureas as cathepsin cysteine protease inhibitors
|
|
CN107074821B
(zh)
|
2014-09-04 |
2020-05-22 |
百时美施贵宝公司 |
为fxia抑制剂的二酰胺大环化合物
|
|
EP3188746B1
(en)
|
2014-09-05 |
2024-06-19 |
The Johns Hopkins University |
Targeting capn9 activity as a therapeutic strategy for the treatment of myofibroblast differentiation and associated pathologies
|
|
WO2016089648A1
(en)
|
2014-12-01 |
2016-06-09 |
Vtv Therapeutics Llc |
Bach 1 inhibitors in combination with nrf2 activators and pharmaceutical compositions thereof
|
|
ES2864839T3
(es)
|
2015-07-02 |
2021-10-14 |
Turning Point Therapeutics Inc |
Macrociclos de diarilo quirales como moduladores de proteína quinasas
|
|
RU2018123825A
(ru)
|
2015-12-07 |
2020-01-15 |
Плексксикон Инк. |
Соединения и способы для модуляции киназ, и показания для этого
|
|
CN105669520B
(zh)
|
2016-01-12 |
2018-10-30 |
山东大学 |
含有色氨酸基本骨架的邻苯二胺类选择性组蛋白去乙酰化酶抑制剂及其制备方法和应用
|
|
AU2017229591B2
(en)
|
2016-03-09 |
2021-08-19 |
Blade Therapeutics Pty Ltd |
Calpain modulators and methods of production and use thereof
|
|
WO2017156071A1
(en)
|
2016-03-09 |
2017-09-14 |
Blade Therapeutics, Inc. |
Cyclic keto-amide compounds as calpain modulators and methods of production and use thereof
|
|
CN109661229B
(zh)
|
2016-06-29 |
2022-06-28 |
加利福尼亚大学董事会 |
用于治疗癌症的化合物和组合物
|
|
EP3481835A4
(en)
|
2016-07-05 |
2020-02-26 |
Blade Therapeutics, Inc. |
CALPAIN MODULATORS AND THERAPEUTIC USE THEREOF
|
|
BR112019006110A2
(pt)
|
2016-09-28 |
2019-09-10 |
Blade Therapeutics Inc |
moduladores de calpaína e usos terapêuticos dos mesmos
|
|
AU2018289434A1
(en)
|
2017-06-23 |
2020-01-16 |
Blade Therapeutics, Inc. |
Calpain modulators and therapeutic uses thereof
|
|
CA3095164A1
(en)
*
|
2018-03-28 |
2019-10-03 |
Blade Therapeutics, Inc. |
Calpain modulators and therapeutic uses thereof
|
|
KR20200139721A
(ko)
|
2018-03-28 |
2020-12-14 |
블레이드 테라퓨틱스, 인크. |
섬유성 질환을 치료하는 방법
|
|
US20210253642A1
(en)
|
2018-05-09 |
2021-08-19 |
Blade Therapeutics, Inc. |
Calpain modulators and therapeutic uses thereof background
|
|
WO2020006294A1
(en)
|
2018-06-28 |
2020-01-02 |
Blade Therapeutics, Inc. |
Methods of treating liver fibrosis using calpain inhibitors
|
|
WO2020006177A1
(en)
|
2018-06-29 |
2020-01-02 |
Blade Therapeutics, Inc. |
Vascular adhesion protein-1 (vap-1) modulators and therapeutic uses thereof
|